View in EDS PDF Full Text

Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies.

Saved in:
Bibliographic Details
Title: Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies.
Authors: Pfeifer Serrahima J; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Schoenfeld K; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany., Kühnel I; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Harwardt J; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany., Macarrón Palacios A; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany., Prüfer M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Kolaric M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Oberoi P; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Kolmar H; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.; Centre for Synthetic Biology, Technical University of Darmstadt, Darmstadt, Germany., Wels WS; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
Source: Frontiers in immunology [Front Immunol] 2024 Aug 29; Vol. 15, pp. 1457887. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39267747
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pfeifer+Serrahima+J%22">Pfeifer Serrahima J</searchLink>; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Schoenfeld+K%22">Schoenfeld K</searchLink>; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Kühnel+I%22">Kühnel I</searchLink>; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Harwardt+J%22">Harwardt J</searchLink>; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Macarrón+Palacios+A%22">Macarrón Palacios A</searchLink>; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Prüfer+M%22">Prüfer M</searchLink>; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Kolaric+M%22">Kolaric M</searchLink>; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Oberoi+P%22">Oberoi P</searchLink>; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Kolmar+H%22">Kolmar H</searchLink>; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.; Centre for Synthetic Biology, Technical University of Darmstadt, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Wels+WS%22">Wels WS</searchLink>; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Aug 29; Vol. 15, pp. 1457887. <i>Date of Electronic Publication: </i>2024 Aug 29 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39267747
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1457887
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1457887
    Titles:
      – TitleFull: Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pfeifer Serrahima J
      – PersonEntity:
          Name:
            NameFull: Schoenfeld K
      – PersonEntity:
          Name:
            NameFull: Kühnel I
      – PersonEntity:
          Name:
            NameFull: Harwardt J
      – PersonEntity:
          Name:
            NameFull: Macarrón Palacios A
      – PersonEntity:
          Name:
            NameFull: Prüfer M
      – PersonEntity:
          Name:
            NameFull: Kolaric M
      – PersonEntity:
          Name:
            NameFull: Oberoi P
      – PersonEntity:
          Name:
            NameFull: Kolmar H
      – PersonEntity:
          Name:
            NameFull: Wels WS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 08
              Text: 2024 Aug 29
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1